|
(BS107) |
Loss of glyoxalase 1 protects heart from failure through induction of aldo-keto reductase |
| |
|
A. R. Saadatmand, J. Morgenstern, M. Freichel, T. Fleming, J. Backs (Heidelberg) |
|
(BS108) |
Effects of Empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: Results from in-vivo experiments and the CINNAMON-study |
| |
|
F. Sinha, S. Klatt, P. Tauber, A. Rietmann, L. S. Maier, F. Schweda, S. Wagner (Regensburg) |
|
(BS109) |
Effects of renal denervation on cardiac and renal damage in different chronic kidney disease rat models |
| |
|
F. Buder, M. Hohl, S.-R. Selejan, P. Markwirth, D. Linz, F. Mahfoud, M. Böhm (Homburg/Saar; Maastricht, NL) |
|
(BS110) |
Dapagliflozin reduces cytosolic calcium transients in a rat model of diabetic cardiomyopathy with preserved ejection fraction |
| |
|
V. Paar, P. Jirak, G. Schulze-Tanzil, M. Kokozidou, F. Föttinger, S. X. Gharibeh, B. Minnich, F. Schrödl, A. Trost, A. Koller, M. Lichtenauer, U. C. Hoppe, L. J. Motloch (Salzburg, AT; Nürnberg) |
|
(BS111) |
Functional Reserve and Contractile Phenotype of Atrial Myocardium from Patients with Atrial Remodeling without and with Atrial Fibrillation |
| |
|
P. Deißler, U. Primessnig, K. L. Tran, V. Falk, B. Pieske, H. Grubitzsch, F. R. Heinzel (Berlin) |
|
(BS112) |
Reduced intracellular calcium buffering promotes development of atrial arrhythmias |
| |
|
V. Möller, F. E. Fakuade, D. Hubricht, Y. Döring, F. E. Mason, N. Voigt, für die Studiengruppe: DZHK (Göttingen) |
|
(BS113) |
Exploring the functional interplay between CaMKII activity and R14del-phospholamban associated cardiomyopathy |
| |
|
M. Martinez Lopez, M. Durashov, B. Foo, J. Backs, H. Silljé, R. De Boer, S. Lehnart (Göttingen, Heidelberg; Groningen, Rotterdam, NL) |
